Monitoring symptoms in cancer patients using remote technology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather real-world clinical and patient-reported data from cancer patients diagnosed with breast, lung, ovarian cancer, multiple myeloma, or acute myelogenous leukemia. Participants will complete a baseline survey and then engage in weekly electronic patient-reported outcome surveys for a minimum of 12 weeks using the Carevive platform. The data collected will contribute to a registry that enhances understanding of patient experiences during active treatment. The study utilizes an electronic care planning system to facilitate remote symptom monitoring.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All participants must be 18 years of age or older.
* Subjects may be any stage and anywhere in the treatment continuum.
* Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
* Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
* All participants must be able to understand English.

Exclusion Criteria:

* Any patient who cannot understand written or spoken English.
* Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
* Any patient on a treatment clinical trial.
* Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Where it's running

• Northshore University Health System
  Evanston, Illinois, United States Recruiting
• Cleveland Clinic Mercy Hospital
  Canton, Ohio, United States Recruiting
• University Hospitals Seidman Cancer Center
  Cleveland, Ohio, United States Recruiting
• Tri-County Hematology & Oncology Associates, Inc.
  Massillon, Ohio, United States Recruiting
• Yale Cancer Center
  New Haven, Connecticut, United States Completed
• Univeristy of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States Completed

Study contacts

• Study coordinator: Julie Scott, Msn
• Email: Julie.scott@healthcatalyst.com
• Phone: 8778423210

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding the experiences of patients with chronic cancer treatments

  This study is trying to understand how people with advanced chronic cancer feel about their targeted treatments by having them share their experiences through interviews and creative expressions like art and music.

  Recruiting University of Alberta · Edmonton, Alberta · NCT05645510

• Validation of a blood test for early cancer detection and monitoring

  This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.

  Recruiting at 3 sites Adela, Inc · Duarte, California and 16 other locations · NCT05366881

• A resource for collecting cancer data and biospecimens

  This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

  Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

• 68Ga-SorB PET/CT imaging for solid tumors

  This study tests a new PET tracer called 68Ga-SorB to see if it can safely and accurately detect tumors in adults with melanoma, liver, lung, breast, pancreatic, ovarian cancer, or cholangiocarcinoma.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07760012

• Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer

  This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586826

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.